Daiichi goes to bond market for refinancing

Daiichi Sankyo, Japan's third-largest drugmaker, plans to sell as much as $3.12 billion in bonds to refinance a loan taken for its $5 billion acquisition of Ranbaxy Laboratories. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.